KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regeneron Pharmaceuticals (REGN) Goodwill & Intangibles (2021 - 2025)

Regeneron Pharmaceuticals has reported Goodwill & Intangibles over the past 5 years, most recently at $1.3 billion for Q4 2025.

  • Quarterly results put Goodwill & Intangibles at $1.3 billion for Q4 2025, up 9.47% from a year ago — trailing twelve months through Dec 2025 was $1.3 billion (up 9.47% YoY), and the annual figure for FY2025 was $1.3 billion, up 9.47%.
  • Goodwill & Intangibles for Q4 2025 was $1.3 billion at Regeneron Pharmaceuticals, down from $1.4 billion in the prior quarter.
  • Over the last five years, Goodwill & Intangibles for REGN hit a ceiling of $1.4 billion in Q3 2025 and a floor of $6.7 million in Q4 2021.
  • Median Goodwill & Intangibles over the past 5 years was $1.0 billion (2023), compared with a mean of $944.3 million.
  • Biggest five-year swings in Goodwill & Intangibles: soared 13564.18% in 2022 and later crashed 85.94% in 2025.
  • Regeneron Pharmaceuticals' Goodwill & Intangibles stood at $6.7 million in 2021, then soared by 13564.18% to $915.5 million in 2022, then rose by 13.45% to $1.0 billion in 2023, then rose by 10.59% to $1.1 billion in 2024, then grew by 9.47% to $1.3 billion in 2025.
  • The last three reported values for Goodwill & Intangibles were $1.3 billion (Q4 2025), $1.4 billion (Q3 2025), and $155.0 million (Q2 2025) per Business Quant data.